Morbid ObesityBARCINONCT06044116
Design and Validation of a Preoperative Calculator for "Textbook Outcome" After Bariatric Surgery (BARCINO)
An observational study of Morbid Obesity, run by Hospital Universitari de Bellvitge at 1 site in Spain.
Trial summary
The present study aims to design, develop and validate a preoperative calculator for "Textbook Outcome" after bariatric surgery, in order to calculate the possibility of not achieving "Textbook outcome" based on the characteristics of the patient and the proposed surgical technique. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Morbid Obesity
- How many people
- 6,000 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jan 2022to 1 Jan 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with morbid obesity who underwent bariatric surgery during years 2015-2021.
Who may be able to join
- Patients who underwent bariatric surgery using laparoscopic sleeve gastrectomy (SG) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic gastric bypass (GBP) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic duodenal switch (DS) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic revisional surgery, from 2015 to 2021 both included.
Who cannot join
- Patients who underwent bariatric surgery using another primary surgical technique that does not be laparoscopic SG, laparoscopic GBP, laparoscopic DS or laparoscopic SADI-S
- patients who underwent bariatric surgery outside the established period (2015-2021).
Trial locations and contacts
1 site in 1 country.
Spain1 site
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907
About this study
Official title: Design and Validation of a Preoperative Calculator for "Textbook Outcome" After Bariatric Surgery: Project BARCINO (BARiatric Surgery Calculator Nomogram for Textbook Outcome)
The present study aims to design, develop and validate a preoperative calculator for "Textbook Outcome" after bariatric surgery, in order to calculate the possibility of not achieving "Textbook outcome" based on the characteristics of the patient and the proposed surgical technique.
Read the detailed description
Morbid obesity is considered the great epidemic of our century. It is regarded as the first non-traumatic cause of death in the western population and it is also progressively beginning to affect developing countries. The latest epidemiological studies estimate that in Spain more than 15% of the population has overweight and about 5% has morbid obesity.
Obesity treatment is multidisciplinary, from lifestyle and dietary changes to surgery. Amongst the different available treatments, bariatric surgery is the only cost-effective in patients with morbid obesity. Bariatric surgery provides better results compared to both pharmacological treatments (which are less available and less effective) and lifestyle changes. Furthermore, as well as weight loss, it guarantees a better control of comorbidities, reducing the risk of cardiovascular disease, morbidity and mortality, improving quality of life. There are several currently standardized bariatric surgical techniques. These techniques can be restrictive (such as sleeve gastrectomy or SG), hypoabsortive (such as duodenal switch or DS and single anastomosis duodeno-ileal bypass with sleeve gastrectomy or SADI-S) or mixed (such as gastric bypass or GBP). The indication will depend on factors such as the patient's BMI, their metabolic comorbidities or the experience of the surgical team, among others. All of them have been shown to be safe in experienced teams, with rates of mortality equal to or less than 0.5% and morbidity less than 10%.
However, although postoperative risks are low, they have to be taken into account in each case individually, along with the potential benefits of surgery as accurately as possible, so the decision whether or not to perform surgical procedure in a consensual manner with the patient can be based on objective data.
Recently, a new concept of measuring postoperative results called "Textbook outcome" (TO) has been introduced. It is a multidimensional measure that is obtained from the sum of several traditional surgical measures: the absence of postoperative complications, no prolongation of hospital stay, no mortality, and no readmissions. The TO reflects what is considered the "ideal" postoperative evolution. In bariatric surgery, TO has been defined as hospital stay equal to or less than 2 days, absence of complications in the first 30 days after surgery, no readmission once discharged in the first 30 days after surgery, and no mortality during the stay hospitalization or during the first 30 days after surgery. Additionally, an ordered TO has been created, ordering these quality indicators from worst to best: mortality, severe complications, readmission, mild complications and prolonged hospitalization stay. The fact of ordering the results with this ordered TO allows to find different combinations of these five indicators in the same patient. It does not happen if, as previously, the combination of all the results of the different parameters generate a binomial result. The ordered TO also has the advantage that allows to identify in the results some individual differences for each hospital, thus making it possible to detect variations between hospitals that can help to improve the quality of surgery and of the hospital in particular, and therefore, improve the clinical result of bariatric surgery, which is not possible with the binomial result since it does not provide information to individual hospitals on which aspect is significantly worse than in the other hospitals. The order of parameters mentioned above was based on expert advice and evidence from the literature regarding what patients considered to be a quality improvement assistant care.
Currently, there is not any tool that calculates preoperatively the risk of not presenting a TO in some of its degrees.
The optimal values of the preoperative variables that allow patients to achieve TO have not been studied either. The aim of this study is to create a calculator that allows calculating the risk that each patient has of not achieving TO based on the patient's variables and the selected surgical technique. This tool could provide relevant information for the patient in the process of informed consent for the surgery, as well as assist in the choice of surgical technique in clinical practice in each specific case. The development of the calculator is intended to be done with the help of machine learning. The Machine learning statistics techniques are a branch of artificial intelligence that allow great flexibility to capture complex non-linear relationships especially when using large amounts of data. The situation where we find ourselves due to the rapid expansion of the COVID-19 pandemic has found doctors and the rest of health professionals unprotected to face with the difficulty of giving an adequate and rapid response to the patients.
- Conditions
- Morbid Obesity
- Keywords
- Obesity, Textbook outcome, Calculator
- Medical subject headings
- Obesity, Morbid, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Calculator design | 5.000 patients of the entire cohort of 6.000 patients will be used for the design of the risk calculator | |
| Internal validation | 1.000 patients of the entire cohort of 6.000 patients will be used for the design of the risk calculator | |
| External validation | Another surgical group from outside Spain will be contacted for external validation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of patients with Textbook outcome after bariatric surgery
Perfect postoperative course, defined as: Hospital stay nor more than 2 days, no complications during the first 30 days after surgery, no hospital readmission during the first 30 days after surgery AND no mortality during hospital stay and/or the first 30 days after surgery.
Measured: From surgery to 30 days after surgery or hospital discharge (if hospital discharge is longer than 30 days after surgery)
Secondary outcomes (1)
Percentage of patients with severe postoperative complications
Severe postoperative complications are those staged IIIA or more with the Clavien-Dindo score
Measured: From surgery to 30 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2023
- Study start1 Jan 2022
- Primary completion1 Jan 2024 (estimated)
- Study completion1 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Morbid ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 6,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital Universitari de Bellvitge
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Javier Osorio, Hospital Universitari de Bellvitge
- Investigators
- Javier Osorio, MD, PhD, Principal investigator, Hospital Universitari de Bellvitge
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06044116
- Sponsor's protocol ID
- HUB-INF-BARCINO
- Acronym
- BARCINO
- Status last verified
- Oct 2023
- First submitted
- 12 Sep 2023
- Last updated
- 19 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Poelemeijer YQM, Marang-van de Mheen PJ, Wouters MWJM, Nienhuijs SW, Liem RSL. Textbook Outcome: an Ordered Composite Measure for Quality of Bariatric Surgery. Obes Surg. 2019 Apr;29(4):1287-1294. doi: 10.1007/s11695-018-03642-1.
PubMed 30569369Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
PubMed 15273542
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Design and Validation of a Preoperative Calculator for "Textbook Outcome" After Bariatric Surgery: Project BARCINO (BARiatric Surgery Calculator Nomogram for Textbook Outcome)
- ClinicalTrials.gov ID
- NCT06044116
- Acronym / sponsor ID
- BARCINO / HUB-INF-BARCINO
- Conditions
- Morbid Obesity
- Keywords
- Obesity, Textbook outcome, Calculator
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 6,000 participants (estimated)
- Lead sponsor
- Hospital Universitari de BellvitgeUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 1 Jan 2024 (estimated)
- Study completion
- 1 Jan 2025 (estimated)
- First posted
- 21 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The present study aims to design, develop and validate a preoperative calculator for "Textbook Outcome" after bariatric surgery, in order to calculate the possibility of not achieving "Textbook outcome" based on the characteristics of the patient and the proposed surgical technique.
Detailed description
Morbid obesity is considered the great epidemic of our century. It is regarded as the first non-traumatic cause of death in the western population and it is also progressively beginning to affect developing countries. The latest epidemiological studies estimate that in Spain more than 15% of the population has overweight and about 5% has morbid obesity.
Obesity treatment is multidisciplinary, from lifestyle and dietary changes to surgery. Amongst the different available treatments, bariatric surgery is the only cost-effective in patients with morbid obesity. Bariatric surgery provides better results compared to both pharmacological treatments (which are less available and less effective) and lifestyle changes. Furthermore, as well as weight loss, it guarantees a better control of comorbidities, reducing the risk of cardiovascular disease, morbidity and mortality, improving quality of life. There are several currently standardized bariatric surgical techniques. These techniques can be restrictive (such as sleeve gastrectomy or SG), hypoabsortive (such as duodenal switch or DS and single anastomosis duodeno-ileal bypass with sleeve gastrectomy or SADI-S) or mixed (such as gastric bypass or GBP). The indication will depend on factors such as the patient's BMI, their metabolic comorbidities or the experience of the surgical team, among others. All of them have been shown to be safe in experienced teams, with rates of mortality equal to or less than 0.5% and morbidity less than 10%.
However, although postoperative risks are low, they have to be taken into account in each case individually, along with the potential benefits of surgery as accurately as possible, so the decision whether or not to perform surgical procedure in a consensual manner with the patient can be based on objective data.
Recently, a new concept of measuring postoperative results called "Textbook outcome" (TO) has been introduced. It is a multidimensional measure that is obtained from the sum of several traditional surgical measures: the absence of postoperative complications, no prolongation of hospital stay, no mortality, and no readmissions. The TO reflects what is considered the "ideal" postoperative evolution. In bariatric surgery, TO has been defined as hospital stay equal to or less than 2 days, absence of complications in the first 30 days after surgery, no readmission once discharged in the first 30 days after surgery, and no mortality during the stay hospitalization or during the first 30 days after surgery. Additionally, an ordered TO has been created, ordering these quality indicators from worst to best: mortality, severe complications, readmission, mild complications and prolonged hospitalization stay. The fact of ordering the results with this ordered TO allows to find different combinations of these five indicators in the same patient. It does not happen if, as previously, the combination of all the results of the different parameters generate a binomial result. The ordered TO also has the advantage that allows to identify in the results some individual differences for each hospital, thus making it possible to detect variations between hospitals that can help to improve the quality of surgery and of the hospital in particular, and therefore, improve the clinical result of bariatric surgery, which is not possible with the binomial result since it does not provide information to individual hospitals on which aspect is significantly worse than in the other hospitals. The order of parameters mentioned above was based on expert advice and evidence from the literature regarding what patients considered to be a quality improvement assistant care.
Currently, there is not any tool that calculates preoperatively the risk of not presenting a TO in some of its degrees.
The optimal values of the preoperative variables that allow patients to achieve TO have not been studied either. The aim of this study is to create a calculator that allows calculating the risk that each patient has of not achieving TO based on the patient's variables and the selected surgical technique. This tool could provide relevant information for the patient in the process of informed consent for the surgery, as well as assist in the choice of surgical technique in clinical practice in each specific case. The development of the calculator is intended to be done with the help of machine learning. The Machine learning statistics techniques are a branch of artificial intelligence that allow great flexibility to capture complex non-linear relationships especially when using large amounts of data. The situation where we find ourselves due to the rapid expansion of the COVID-19 pandemic has found doctors and the rest of health professionals unprotected to face with the difficulty of giving an adequate and rapid response to the patients.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Calculator design | – | –5.000 patients of the entire cohort of 6.000 patients will be used for the design of the risk calculator |
| Internal validation | – | –1.000 patients of the entire cohort of 6.000 patients will be used for the design of the risk calculator |
| External validation | – | –Another surgical group from outside Spain will be contacted for external validation |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with morbid obesity who underwent bariatric surgery during years 2015-2021.
Key inclusion criteria (5 listed)
- Patients who underwent bariatric surgery using laparoscopic sleeve gastrectomy (SG) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic gastric bypass (GBP) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic duodenal switch (DS) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) from 2015 to 2021 both included.
- Patients who underwent bariatric surgery using laparoscopic revisional surgery, from 2015 to 2021 both included.
Key exclusion criteria (2 listed)
- Patients who underwent bariatric surgery using another primary surgical technique that does not be laparoscopic SG, laparoscopic GBP, laparoscopic DS or laparoscopic SADI-S
- patients who underwent bariatric surgery outside the established period (2015-2021).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage of patients with Textbook outcome after bariatric surgery
Time frame: From surgery to 30 days after surgery or hospital discharge (if hospital discharge is longer than 30 days after surgery)
Perfect postoperative course, defined as: Hospital stay nor more than 2 days, no complications during the first 30 days after surgery, no hospital readmission during the first 30 days after surgery AND no mortality during hospital stay and/or the first 30 days after surgery.
1 secondary outcome
Percentage of patients with severe postoperative complications
Time frame: From surgery to 30 days after surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2023.
- Background: PubMed 30569369Poelemeijer YQM, Marang-van de Mheen PJ, Wouters MWJM, Nienhuijs SW, Liem RSL. Textbook Outcome: an Ordered Composite Measure for Quality of Bariatric Surgery. Obes Surg. 2019 Apr;29(4):1287-1294. doi: 10.1007/s11695-018-03642-1.
- Background: PubMed 15273542Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
Related trials for Morbid Obesity
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruitingObservational study
Evaluating Metabolic Health in Individuals With Extreme Obesity
BMI>40
Enrolling by invitationObservational study
Bariatric Surgery Registry
Obesity, Morbid
Not yet recruitingObservational study
Serum Estradiol and Endometrial Thickness After Bariatric Surgery in Postmenopausal Women With Obesity
Obesity, Morbid, Postmenopause
Active, not recruiting
Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients
Obesity, Morbid, Eating Disorder Symptom
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Javier Osorio, MD, PhD principal investigator
Hospital Universitari de Bellvitge
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Morbid Obesity, run by Hospital Universitari de Bellvitge at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of patients with Textbook outcome after bariatric surgery (time frame: From surgery to 30 days after surgery or hospital discharge (if hospital discharge is longer than 30 days after surgery)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06044116, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2023.